Latest Corporate News
Fosun Pharmaceutical to Spin Off Vaccine Unit on Hong Kong Exchange
Shanghai-based Fosun Pharmaceutical will spin off its vaccine subsidiary, Fosun Adgenvax Biopharmaceutical, for listing on the Hong Kong stock exchange to boost R&D funding. The parent company is already listed in Shanghai and Hong Kong, amid biotech firms raising over US$1.5 billion in Hong Kong last year.
The Hang Seng Innovative Drug Index has surged 70% in a year.
China Merchants Bank Reports Flat Revenue but Profit Growth for 2025
China Merchants Bank announced 2025 preliminary results with revenue steady at 337.53 billion yuan (US$46.8 billion) after a 2024 decline. Net profit rose 1.2% to 150 billion yuan, with total assets up 7.56% to over 13 trillion yuan.
Asset quality remained stable, maintaining leadership in retail banking.
Geovis Technology Forecasts Up to 91% Profit Decline in 2025
Geovis Technology expects 2025 net profit between 30-45 million yuan (US$4.3-6.4 million), down as much as 91% year-over-year. Slower traditional business growth and shift to commercial space and low-altitude economy sectors drove the drop.
Higher R&D and operating expenses also impacted earnings.
Janus Henderson Acquires Richard Bernstein Advisors
Janus Henderson Group entered a definitive agreement for 100% of Richard Bernstein Advisors, a macro multi-asset manager. The deal positions Janus as a leading model portfolio and SMA provider.
Founded in 2009, RBA is headquartered in New York.
Announced January 23, 2026.
Forge Global Stockholders Approve Merger with Charles Schwab
Forge Global Holdings received stockholder approval for its acquisition by The Charles Schwab Corporation. Forge provides private market infrastructure, data, and investment solutions.
9,687,311 shares were represented at the special meeting.
Announced January 22, 2026.
General Fusion Announces $1 Billion SPAC Merger for Nasdaq Listing
Canadian fusion developer General Fusion revealed a $1 billion merger with a SPAC to list on Nasdaq mid-2026, becoming the first public fusion company. The deal funds demonstration of magnetized target fusion tech amid AI-driven power demand.
Total funding nears $400 million, including from Jeff Bezos.
Perimeter Solutions Acquires Medical Management Technologies for $685M
Perimeter Solutions, Inc. (NYSE: PRM) acquired Medical Manufacturing Technologies LLC from Arcline for $685 million. MMT supplies machinery for minimally invasive medical devices.
Nixon Peabody advised on the deal.
Announced January 23, 2026.